WISeKey Technologies Mitigate Cybersecurity Risks and Vulnerabilities Related to the Recent U.S. Treasury Department Breach The recent breach underscores the […]
Data support favorable safety and tolerability profile with no serious adverse events (SAEs) or study-related drug discontinuations Enrollment to be […]
Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of […]